NCT00292487View on ClinicalTrials.gov

Patients With Renal Impairment Undergoing CT

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Contrast Induced Nephropathy
Interventions
DRUG

Iopamidol 370 mgI/mL

Trial Locations (1)

08543

Bracco Diagnostics, Inc, Princeton

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY